Menu Search
Equities

Fortive Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
F03:MUN

Fortive Corp

Actions
  • Price (EUR)44.00
  • Today's Change0.90 / 2.09%
  • Shares traded10.00
  • 1 Year change-14.89%
  • Beta1.0890
Data delayed at least 15 minutes, as of Jul 01 2025 07:09 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fortive Corporation is a technology solutions company. The Company's businesses design, develop, manufacture, and market products, software, and services, building on brand names, technologies, and market positions. The Company's segments include Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). The Company's IOS segment provides advanced instrumentation, software and services to various customers enabling their mission-critical workflows. These offerings include electrical test and measurement, facility and asset lifecycle software applications, connected worker safety and compliance solutions across a range of vertical end markets. Its AHS segment supplies critical workflow solutions enabling healthcare providers to deliver patient care more efficiently. Its offerings include instrument sterilization solutions, instrument tracking, biomedical test tools, radiation detection and safety monitoring and end-to-end clinical productivity software and solutions.

  • Revenue in USD (TTM)6.18bn
  • Net income in USD797.40m
  • Incorporated2015
  • Employees18.00k
  • Location
    Fortive Corp6920 Seaway BlvdEVERETT 98203-5829United StatesUSA
  • Phone+1 (425) 446-5000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.fortive.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.